Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Medpace Announces the Addition of Brian Murphy, MD, MPH, Medical Director, Strengthening Medpace’s Therapeutic Expertise in Infectious Disease and Pediatric Drug Development

"Dr. Murphy’s reputation as an academic leader, combined with his years of experience in clinical development makes him a perfect fit for Medpace," said Jonathan Isaacsohn, MD, FACC, Executive Vice President, Medpace. "He will contribute to Medpace’s entry into one of the major therapeutic areas that poses challenges for emerging markets, that of infectious disease and the need for new and effective vaccines."

Dr. Brian Murphy brings to the Medpace medical management team over ten years of work at the University of Kentucky where he most recently served as Assistant Professor in the Division of Infectious Disease, the Department of Pediatrics, and the Department of Microbiology, Immunology, and Molecular Genetics. He has worked with multi-disciplinary translational/clinical research teams as the principal investigator and consultant on multiple funded projects investigating the pathogenesis and management of HIV, pulmonary infections, infections affecting immunocompromised patients and patients with chronic lung diseases i.e., cystic fibrosis and chronic obstructive pulmonary disease, fungal diseases, vaccine development, bioterrorism, and immunotherapeutics.

Dr. Murphy received his Doctor of Medicine degree from the University of Louisville and his undergraduate diploma in biology from the University of Louisville. Dr Murphy also received his Master of Public Heath in Epidemiology from the University of Kentucky.